Neuberger Berman Group
HALO icon

Neuberger Berman Group’s Halozyme HALO Stock Holding History

Neuberger Berman Group’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21M Buy
267,855
+240,442
+877% +$16.4M 0.01% 705
2026
Q1 		$1.77M Buy
27,413
+477
+2% +$33.6K ﹤0.01% 1222
2025
Q4 		$1.81M Sell
26,936
-838
-3% -$56.4K ﹤0.01% 1213
2025
Q3 		$2.04M Sell
27,774
-154,826
-85% -$10.3M ﹤0.01% 1161
2025
Q2 		$9.5M Sell
182,600
-279,927
-61% -$15.9M 0.01% 809
2025
Q1 		$29.5M Buy
462,527
+86,981
+23% +$5.05M 0.02% 539
2024
Q4 		$18M Buy
375,546
+89,464
+31% +$4.59M 0.01% 687
2024
Q3 		$16.4M Buy
286,082
+9,059
+3% +$519K 0.01% 700
2024
Q2 		$14.5M Buy
277,023
+17,342
+7% +$761K 0.01% 711
2024
Q1 		$10.6M Sell
259,681
-93,231
-26% -$3.49M 0.01% 777
2023
Q4 		$13M Buy
352,912
+168,459
+91% +$6.34M 0.01% 853
2023
Q3 		$7.05M Buy
184,453
+1,542
+0.8% +$63.2K 0.01% 808
2023
Q2 		$6.6M Buy
182,911
+41,590
+29% +$1.42M 0.01% 830
2023
Q1 		$5.4M Buy
141,321
+6,909
+5% +$324K 0.01% 860
2022
Q4 		$7.65M Sell
134,412
-43,849
-25% -$2.24M 0.01% 797
2022
Q3 		$7.05M Buy
178,261
+2,907
+2% +$128K 0.01% 809
2022
Q2 		$7.72M Buy
175,354
+9,079
+5% +$393K 0.01% 801
2022
Q1 		$6.63M Buy
166,275
+6,854
+4% +$244K 0.01% 896
2021
Q4 		$6.35M Sell
159,421
-438
-0.3% -$16.4K 0.01% 925
2021
Q3 		$6.42M Sell
159,859
-71,203
-31% -$2.98M 0.01% 897
2021
Q2 		$10.5M Buy
231,062
+17,907
+8% +$793K 0.01% 814
2021
Q1 		$8.89M Buy
213,155
+64,399
+43% +$2.94M 0.01% 841
2020
Q4 		$6.35M Buy
148,756
+2,006
+1% +$72.1K 0.01% 860
2020
Q3 		$3.86M Buy
146,750
+34,000
+30% +$947K ﹤0.01% 913
2020
Q2 		$3.02M Buy
112,750
+33,000
+41% +$744K ﹤0.01% 923
2020
Q1 		$1.44M Buy
+79,750
New +$1.51M ﹤0.01% 1017
2018
Q1 		– Sell
-40,000
Closed -$810K – 1705
2017
Q4 		$810K Buy
+40,000
New +$735K ﹤0.01% 1277
2013
Q3 		– Sell
-11,000
Closed -$87K – 1629
2013
Q2 		$87K Buy
+11,000
New +$70.1K ﹤0.01% 1544

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Neuberger Berman Group's HALO Position: Q2 2026 in Review

Neuberger Berman Group increased its Halozyme (HALO) stake by 877% in Q2 2026, buying an estimated $16.4M and bringing the position to 267,855 shares worth $21M. The position accounts for 0.01% of the portfolio, ranked #705.

Neuberger Berman Group first reported a position in HALO in Q2 2013 and has held it in 28 quarters since. The position peaked at $29.5M in Q1 2025. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Neuberger Berman Group held 267,855 shares of Halozyme worth $21M as of Q2 2026.
  • Neuberger Berman Group bought 240,442 Halozyme shares in Q2 2026, an estimated $16.4M.
  • Halozyme made up 0.01% of Neuberger Berman Group's portfolio in Q2 2026, its #705 holding.
  • Neuberger Berman Group first reported a position in Halozyme in Q2 2013 and has held it in 28 quarters since.
  • Neuberger Berman Group's Halozyme position peaked at $29.5M in Q1 2025.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.